XL Congresso Società Italiana di Neurologia PADOVA 21-25 ...
XL Congresso Società Italiana di Neurologia PADOVA 21-25 ...
XL Congresso Società Italiana di Neurologia PADOVA 21-25 ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
COMUNICAZIONI ORALI: NEUROGENETICA 1<br />
ore 11.30 - 13.30<br />
Moderatori<br />
N. BRESOLIN (Milano) - M. ZEVIANI (Milano)<br />
11.30 AFG3L2 MUTATIONS CAUSE AUTOSOMAL DOMINANT ATAXIA SCA28<br />
AND REVEAL AN ESSENTIAL ROLE OF THE MITOCHONDRIAL M-AAA<br />
AFG3L2 HOMOCOMPLEX IN THE CEREBELLUM<br />
D. DI BELLA, F. LAZZARO, A. BRUSCO, G. BATTAGLIA, A. PASTORE, A. FINARDI,<br />
V. FRACASSO, S. MAGRI, M. PLUMARI, C. CAGNOLI, F. TEMPIA, A. BRUSSINO,<br />
C. GELLERA, C. MARIOTTI, P. PLEVANI, S. DI DONATO, T. LANGER, M. MUZI-<br />
FALCONI, F. TARONI (Milano, Torino, Londra - UK, Köln - D)<br />
11.45 EARLY-ONSET SCA2 : CLINICAL AND GENETIC CONSIDERATIONS<br />
C. CASALI, R. DI FABIO, K. MICHAILIDIS, A. TESSA, M. LE ROSE, E. BERTINI,<br />
F. PIERELLI, F. SANTORELLI (Roma)<br />
12.00 A CASE OF SPINOCEREBELLAR ATAXIA TYPE 17 (SCA 17)<br />
S. PAGLIONICO, D. BOSCO, M. SALSONE, M. MORELLI, F. NOVELLINO, G. ARABIA,<br />
D. MESSINA, G. NICOLETTI, G. ANNESI, A. QUATTRONE (Catanzaro, Piano Lago <strong>di</strong><br />
Mangone - CS, Crotone)<br />
12.15 SPINOCEREBELLAR ATAXIA TYPE 15: CLINICAL AND MOLECULAR-<br />
GENETIC FEATURES OF TWO ITALIAN FAMILIES<br />
G. VAULA, M. GODANI, E. DI GREGORIO, A. BRUSCO, A. BRUSSINO, C. CAGNOLI,<br />
S. JENSEN, E. SALMON, G. FERRARI, L. PINESSI, L. ORSI (Torino, La Spezia, Carrara,<br />
Liegi - B, Ivrea - TO)<br />
12.30 SINGLE-CENTER, OPEN-LABEL, SEQUENTIAL TRIAL TO TEST THE<br />
EFFICACY, SAFETY AND TOLLERABILITY OF EPOETIN ALFA IN PATIENTS<br />
WITH FRIEDREICH’S ATAXIA<br />
F. SACCÀ, A. GUACCI, R. PIRO, A. ANTENORA, G. PUORRO, A. DENARO, A. MARSILI,<br />
F. ACQUAVIVA, S. COCOZZA, G. DE MICHELE, A. FILLA (Napoli)<br />
12.45 OUTCOME AFTER TWO YEARS OF ENZYME REPLACEMENT THERAPY<br />
(ERT) IN 29 PATIENTS WITH LATE-ONSET TYPE II GLYCOGENOSIS<br />
(GSDII)<br />
S. RAVAGLIA, B. BEMBI, M. ROSSI, G. PICCOLO, A. PICHIECCHIO, A. REPETTO,<br />
M. GRANDIS, A. COSTA, C. DANESINO, A. MOGLIA (Pavia, U<strong>di</strong>ne, Genova)<br />
13.00 NEUROLOGICAL MANIFESTATIONS IN THE ATRX SYNDROME<br />
S. A. MUSUMECI, G.A. VITELLO, C. SCUDERI, S.G. ROMANO, C. BARONE, M. ELIA,<br />
M. FICHERA, M. LO GIUDICE, E. BORGIONE (Troina - EN)<br />
13.15 GAIN OF GLYCOSYLATION AS A POSSIBLE MECHANISM OF MYELIN<br />
PROTEIN ZERO MUTATIONS<br />
M. GRANDIS, S. SCAZZOLA, M. BONO, M. PASSALACQUA, P. LUZZI, E. BELLONE,<br />
G. MANCARDI, P. MANDICH, M. SHY, A. SCHENONE (Genova, Detroit - USA)<br />
13.30 - 14.30 Pausa pranzo<br />
<strong>25</strong><br />
22<br />
N<br />
O<br />
V<br />
E<br />
M<br />
B<br />
R<br />
E<br />
•<br />
G<br />
I<br />
A<br />
N<br />
B<br />
A<br />
T<br />
T<br />
I<br />
S<br />
T<br />
A<br />
D<br />
A<br />
M<br />
O<br />
N<br />
T<br />
E